Gita A Toyserkani

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Pulmonary Arterial Hypertension

Drug Administration

Top Venues

Pharmaceutical medicine

Clinical pharmacology and therapeutics

BMC health services research

This page only lists publications with an associated author ORCID identifier.

Publications

Ameet Sarpatwari, Zhigang Lu, Massimiliano Russo, Heidi Zakoul, Su Been Lee, Gita A Toyserkani, Esther H Zhou, Cynthia LaCivita, Katherine Hyatt Hawkins Shaw, Laura Zendel, Gerald J Dal Pan, Aaron S Kesselheim
How Do Risk Evaluation and Mitigation Strategies Impact Clinical Practice? A National Survey of Physicians. Clinical pharmacology and therapeutics (2024)
Ameet Sarpatwari, Zhigang Lu, Massimiliano Russo, Heidi Zakoul, Su Been Lee, Gita A Toyserkani, Esther H Zhou, Cynthia LaCivita, Katherine Hyatt Hawkins Shaw, Laura Zendel, Gerald J Dal Pan, Aaron S Kesselheim
How Do Risk Evaluation and Mitigation Strategies Impact Clinical Practice? A National Survey of Physicians. Clinical pharmacology and therapeutics 115 (6) (2024)
Gita A Toyserkani, Joann H Lee, Esther H Zhou
The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities. Pharmaceutical medicine (2023)
Gita A Toyserkani, Joann H Lee, Esther H Zhou
Correction to: The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities. Pharmaceutical medicine (2023)
Gita A Toyserkani, Samuel B Ewusie, Philip J Turk, Janifer Quick, Elaine H Morrato
Evolution of Cross-Sectional Survey Protocol Quality Over Time: A Case Series of Index U.S. REMS Knowledge Survey Protocols (2007-2020). Drug safety (2023)
Linda Huynh, Gita A Toyserkani, Elaine H Morrato
Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014-2018). BMC health services research 21 (1) (2021)